Psygen is a manufacturer of pharmaceutical-grade psychedelic API products for pre-clinical and clinical research and, eventually commercial therapeutic applications. The Company’s principal products are psilocybin and DMT. Psygen also intends to pursue a drug development program for the application of LSD in psychotherapy.
Location: Canada, Alberta, Calgary
Investors 3
| Date | Name | Website |
| - | Iter Inves... | iterinvest... |
| - | Noetic Fun... | noeticfund... |
| - | Vine Ventu... | vine.vc |
Mentions in press and media 5
| Date | Title | Description | Source |
| 17.01.2022 | Psygen Receives Dealer's Licence from Health Canada | Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Psygen Industries Ltd. (together with its su... | marketscre... |
| 07.10.2021 | CORRECTION FROM SOURCE: Psygen Announces use of Psilocybin i... | patent applications filed for manufacturing processes patent-pending technology aims to improve yiel... | marketscre... |
| 06.10.2021 | Psygen Announces That Psilocybin from Its Patent-Pending Pro... | patent applications filed for manufacturing processes patent-pending technology aims to improve yiel... | marketscre... |
| 05.08.2021 | Psygen Announces Successful Closing of Oversubscribed Conver... | Calgary, Alberta--(Newsfile Corp. - August 5, 2021) - Psygen Industries Ltd. ("Psygen" or ... | marketscre... |
| 19.04.2021 | Psygen Industries Ltd. and 1290442 B.C. Ltd. Announce Execut... | Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - Further to the press release of Psy... | marketscre... |